Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report)’s stock price reached a new 52-week high on Monday . The stock traded as high as $45.21 and last traded at $45.07, with a volume of 40387 shares. The stock had previously closed at $44.17.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada lowered shares of Sandoz Group from a “moderate buy” rating to a “hold” rating in a report on Monday, September 16th.
Check Out Our Latest Analysis on SDZNY
Sandoz Group Stock Performance
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
- Five stocks we like better than Sandoz Group
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What is a support level?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How to Invest in Blue Chip Stocks
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
